We are live on
!
Find out more
Boston Partners Portfolio holdings
AUM
$113B
Turnover
18.52%
1-Year Est. Return
38.87%
This Fund
S&P 500
This Quarter
Est. Return
+0.94%
1 Year Est. Return
+38.87%
3 Year Est. Return
+108.29%
5 Year Est. Return
+142.95%
10 Year Est. Return
+500.61%
AUM
$67.9B
AUM Growth
-$1.92B
(-2.7%)
Cap. Flow
-$1.61B
Cap. Flow
% of AUM
-2.37%
Top 10 Holdings %
Top 10 Hldgs %
16.65%
Holding
792
New
60
Increased
302
Reduced
281
Closed
78
Avg Time Held
1.7
years
Top 10 Avg Time Held
1.8
years
Top 20 Avg Time Held
1.3
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bank of America
BAC
|
+$761M |
| 2 |
PPG Industries
PPG
|
+$342M |
| 3 |
Pultegroup
PHM
|
+$278M |
| 4 |
Apple
AAPL
|
+$233M |
| 5 |
UnitedHealth
UNH
|
+$211M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$701M |
| 2 |
Medtronic
MDT
|
+$355M |
| 3 |
Lockheed Martin
LMT
|
+$309M |
| 4 |
TOWERS WATSON & CO COM STK CL A (DE)
TW
|
+$286M |
| 5 |
Western Digital
WDC
|
+$252M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 26.4% |
| 2 | Technology | 13.5% |
| 3 | Healthcare | 12.95% |
| 4 | Industrials | 11.68% |
| 5 | Energy | 8.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
626
Johnson Outdoors
JOUT
$455M
| $1.93M | ﹤0.01% |
87,052
| – | – |
2015 Q2
3 quarters
|
|
|
SCMP
627
DELISTED
Sucampo Pharmaceuticals, Inc.
SCMP
| $1.91M | ﹤0.01% |
+174,554
| New | +$2.21M |
2016 Q1
0 quarters
|
|
628
3M
MMM
$85.3B
| $1.86M | ﹤0.01% |
13,341
| – | – |
2013 Q2
11 quarters
|
|
629
Pan American Silver
PAAS
$18.1B
| $1.84M | ﹤0.01% |
169,131
| – | – |
2015 Q2
3 quarters
|
|
630
Shoe Station Group
SHOE
$376M
| $1.83M | ﹤0.01% |
135,612
-40,288
| -23% | -$479K |
2014 Q2
7 quarters
|
|
631
Civeo
CVEO
$318M
| $1.82M | ﹤0.01% |
123,020
-123,092
| -50% | -$1.64M |
2015 Q1
4 quarters
|
|
632
Costamare
CMRE
$1.73B
| $1.78M | ﹤0.01% |
200,596
+45,081
| +29% | +$353K |
2015 Q4
1 quarter
|
|
633
PC Connection
CNXN
$2.29B
| $1.78M | ﹤0.01% |
69,024
+13,349
| +24% | +$305K |
2014 Q3
6 quarters
|
|
634
Gerdau
GGB
$9.91B
| $1.78M | ﹤0.01% |
1,260,000
-252,000
| -17% | -$224K |
2013 Q2
11 quarters
|
|
635
Pure Cycle
PCYO
$268M
| $1.77M | ﹤0.01% |
392,885
+344,491
| +712% | +$1.55M |
2015 Q4
1 quarter
|
|
636
DELISTED
DigitalBridge
DBRG
| $1.77M | ﹤0.01% |
39,008
+13,380
| +52% | +$591K |
2015 Q4
1 quarter
|
|
637
Natural Gas Services Group
NGS
$399M
| $1.74M | ﹤0.01% |
80,344
-9,076
| -10% | -$173K |
2013 Q4
9 quarters
|
|
638
DELISTED
Theravance Biopharma
TBPH
| $1.74M | ﹤0.01% |
+92,310
| New | +$1.51M |
2016 Q1
0 quarters
|
|
|
CDI
639
DELISTED
CDI Corp.
CDI
| $1.71M | ﹤0.01% |
272,613
| – | – |
2015 Q4
1 quarter
|
|
640
Wynn Resorts
WYNN
$7.93B
| $1.69M | ﹤0.01% |
+18,099
| New | +$1.34M |
2016 Q1
0 quarters
|
|
641
Babcock & Wilcox
BW
$739M
| $1.68M | ﹤0.01% |
7,834
| – | – |
2015 Q3
2 quarters
|
|
642
DELISTED
Cross Country Healthcare
CCRN
| $1.67M | ﹤0.01% |
+143,530
| New | +$1.82M |
2016 Q1
0 quarters
|
|
643
Ducommun
DCO
$2.58B
| $1.65M | ﹤0.01% |
108,430
+11,050
| +11% | +$160K |
2015 Q4
1 quarter
|
|
644
Trip.com Group
TCOM
$25.1B
| $1.63M | ﹤0.01% |
+36,744
| New | +$1.54M |
2016 Q1
0 quarters
|
|
645
ArcBest
ARCB
$2.97B
| $1.61M | ﹤0.01% |
74,500
| – | – |
2015 Q4
1 quarter
|
|
646
BGC Group
BGC
$5.41B
| $1.59M | ﹤0.01% |
273,293
| – | – |
2015 Q4
1 quarter
|
|
|
HWCC
647
DELISTED
Houston Wire & Cable Company
HWCC
| $1.54M | ﹤0.01% |
220,046
| – | – |
2015 Q2
3 quarters
|
|
|
ALSK
648
DELISTED
Alaska Communications Systems
ALSK
| $1.52M | ﹤0.01% |
852,866
| – | – |
2015 Q2
3 quarters
|
|
649
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
| $1.51M | ﹤0.01% |
10,572
| – | – |
2015 Q4
1 quarter
|
|
650
Grupo Aeroportuario del Sureste
ASR
$7.05B
| $1.5M | ﹤0.01% |
10,000
-5,000
| -33% | -$683K |
2015 Q4
1 quarter
|
|
Similar funds
Boston Partners's Q1 2016 Portfolio in Review
As of Q1 2016, Boston Partners held 792 positions worth $67.9B, down 2.7% from $69.8B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Boston Partners's Q1 2016 filing shows 60 new, 302 increased, 281 reduced and 78 closed positions. Its largest new stake was Pultegroup: 16,274,531 shares worth $304M. The largest sale was Pfizer, an estimated $701M.
By sector, the portfolio is most concentrated in Financials at 26% of assets, down from 27% a quarter earlier, followed by Technology and Healthcare.
- Boston Partners's largest Q1 2016 buy was Pultegroup: 16,274,531 shares worth $304M.
- Boston Partners added most to Bank of America in Q1 2016, an estimated $761M increase.
- Boston Partners's biggest Q1 2016 reduction was Pfizer, cutting an estimated $701M.
- Boston Partners fully exited TOWERS WATSON & CO COM STK CL A (DE) in Q1 2016, selling an estimated $286M.
- Boston Partners's ten largest holdings make up 17% of its $67.9B portfolio in Q1 2016.
- Boston Partners opened 60 new positions and closed 78 in Q1 2016.
- Boston Partners's portfolio value fell 2.7% quarter-over-quarter to $67.9B.
Based on Boston Partners's 13F filing for Q1 2016, filed 12 May 2016.